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Abstract  
Conclusion. In Kikuchi-Fujimoto disease (KFD), low ratio of blastic cells (<70%) in 
the lymph node specimens and absence of atypical lymphocytes in the peripheral blood 
are the predictive factors which may protract the clinical course. 
Objectives. Since KFD is a self-limiting disorder that does not require any specific 
management, its prognostic factors have received little attention. In the present study, 
we observed the clinical and pathological factors which may affect the period from 
onset to cure of KFD. 
Methods: Forty three KFD patients that underwent lymph node biopsy and diagnosed 
by immunohistochemical staining at Okayama University Hospital and Okayama 
Medical Center from January 2001 to December 2013 were enrolled in this 
retrospective study. 
Results: The total period from the onset to the cure of the disease was 1-37 months 
(mean, 6 months, median, 9.4 months). Low ratio of blastic cell proliferation area 
(<70%) in the lymph node specimens (p=0.011) and absence of atypical lymphocytes in 
the peripheral blood (p=0.026) were associated with relatively long duration of KFD.  
Key Words: Kikuchi-Fujimoto disease, atypical lymphocytes, blastic cell, prognostic 
factors.
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Introduction 
The clinical characteristics of histiocytic necrotizing lymphadenitis, also known as 
Kikuchi-Fujimoto disease (KFD), are cervical lymphadenopathy with tenderness and 
fever, with a high prevalence among young Asian women. Typical histologic findings of 
KFD include paracortical areas of coagulative necrosis with abundant karyorrhectic 
debris, and karyorrhectic foci consist of various types of hystiocytes, immunoblasts, and 
small and large lymphocytes [1]. Since the prognosis of KFD is usually good with the 
condition resolving spontaneously within a period of several months [2], its prognostic 
factors have received little attention. However, it will often take more than a year from 
the onset of KFD to the cure of the disease, and the patients may feel uneasy and 
irritating. Therefore it may be convenient if there are some predictive factors which may 
affect the period from onset of KFD to cure of the disease. They may also be helpful to 
decide whether we undergo steroid therapy or not. The present study analyzed several 
prognostic factors including clinical characteristics, blood examination, and 
pathological findings. Among the pathological findings, we especially focused on the 
occupation of blastic cell proliferation and coagulative necrosis in each of the 
specimens.  
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Patients and methods 
We identified 43 KFD cases by reviewing medical and pathological records between 
January 2001 and December 2013 at Okayama University Hospital and Okayama 
Medical Center. The 43 KFD cases in the present study were diagnosed by open surgical 
biopsy or cutting needle biopsy. The lymph node specimens obtained by biopsy were 
fixed in buffered formalin, embedded in paraffin, and then stained with hematoxylin and 
eosin. Automated immunostainers Ventana (Ventana Medical Systems, Tucson, AZ, 
USA) or Bond Max (Leica Biosystems, Melbourne, Australia) were used to perform 
immunohistochemical studies. The following primary antibodies were used: CD3 
(LN10, Novocastra, UK; 1:200), CD4 (1F6, Nichirei, Japan; 1:40), CD8 (C8/144B, 
Nichirei; 1:100), CD20 (L26, Dako, Denmark; 1:200), CD68 (KP1, Dako; 1:200), Ki67 
(MIB-1, Novocastra; 1:2500), lysozyme (LZM) (polyclonal, Dako; 1:1000), and 
myeloperoxidase (MPO)  (polyclonal, Dako; 1:1500). LZM and MPO were stained 
using Ventana and CD3, CD4, CD8, CD20, CD68, and Ki67 were stained using Bond 
Max. 
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Results 
Overall outcomes.  
Of the 43 patients (Table 1), ages ranged from 11 to 59 years, and the mean age 
was 29 years. Fourteen (33%) were males and 29 (67%) were females. Twenty seven 
patients (63%) experienced fever over 37 °C, 24 (56%) felt pain, and 12 (28%) felt 
general fatigue. Twenty five (58%) patients had KFD at warm season in Japan (spring 
and summer; between March and August). In laboratory findings, the average of white 
blood cell counts (WBC) was 4119/µl (reference range, 3500-8500/µl), lactate 
dehydrogenase (LDH), 228.7 IU/L (120-240 IU/L), soluble interleukin-2 receptor 
(sIL-2R), 755.5 U/ml (122-496 U/ml), and C-reactive protein (CRP), 0.98 mg/dl 
(0.00-0.30 mg/dl), respectively. In 9 (21%) patients, atypical lymphocytes were 
observed in the periphery blood. Fourteen (33%) of 42 patients were smokers, and 9 
(21%) of 42 were drinkers. Thirty eight (90%) of 42 patients took nonsteroidal 
anti-inflammatory drug (NSAID). Thirty one (72%) of 43 patients took antibiotic, and 
12 (28%), steroid, respectively. The total period from the onset to the cure of the disease 
was 1-37 months (mean, 6 months, median, 9.4 months). 
Affected lymph nodes were located in the cervical area in 42 of the 43 patients, 
and the remaining 1 patient had generalized lymphadenopathy, who was finally 
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diagnosed with concurrent systemic lupus erythematosus (SLE). Pathological studies 
showed large number of histiocytes, many of which were crescentic, at the margin of 
the necrotic area (Figure 1a). Immunohistochemical studies revealed that the infiltrated 
lymphocytes mainly consisted of CD3-positive T cells and there were only a few 
CD20-positive B cells. There was a predominance of CD8-positive large lymphoid cells 
with blastic features more than CD4-positive cells (Figure 1b). The CD8-positive large 
lymphoid cells revealed that the Ki67 labeling index was relatively high. In all cases, 
MPO (Figure 1c) was detected among LZM (Figure 1d) and CD68-positive histiocytes. 
The extent of the CD8-positive large lymphoid cell (blastic cell) occupation to the entire 
area of the specimens was over 70% in 10 (23%) cases (Figure 2a), and that of 
coagulative necrosis was over 50% in 7 (16%) cases (Figure 2b). All cases were 
clinically and pathologically consistent with KFD, and the accuracy of the diagnoses 
was confirmed by their clinical courses. 
Statistical analysis of prognostic factors.  
In the present study, the subjects of which data was not perfect (sIL-2R, smoker or not, 
drinker or not, took NSAID or not) were looked upon as reference data and were 
excluded from multivariate analysis even if their data had a significant difference in 
univariate analysis. The results of univariate analyses for these characteristics are shown 
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in Tale 1. Onset in warm season, absence of atypical lymphocyte in peripheral blood, 
and blastic cell occupation to the entire area ≤70% in the histopathological studies were 
the factors which significantly protracted clinical course (p<0.05). Fever, general fatigue, 
and with steroid therapy had a tendency to protract clinical course (p<0.1). Although it 
was reference data, sIL-2R ≤1000 U/ml was also a negative prognostic factor 
(p=0.0050). Multivariate analyses to evaluate the simultaneous effects of variables 
which affect the period from the onset of KFD to cure of the disease (Table 2) showed 
absence of atypical lymphocyte in peripheral blood and blastic cell occupation to the 
entire area ≤70% in histopathological studies were independent factors which associated 
with protraction of the disease. There were no statistical significant factors which may 
cause recurrence of KFD (data not shown).  
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Discussion 
The duration of KFD is generally reported as 1 to 4 months [1]. In the present 
study, the period from the onset to the cure of the disease was 1-37 months (mean, 6 
months, median, 9.4 months). We speculated that in other studies many patients’ 
follow-up might be suspended with improvement of their complaints, not with complete 
improvement of lymphadenopathy. Otherwise, the present study may suffer from 
selection bias because we enrolled biopsy-confirmed patients, and we tend not to 
perform surgical open biopsy in patients with mild symptoms or quick recovery.  
There were no significant clinical characteristics which may affect the duration 
of KFD. Since an infectious etiology has been postulated, we had nominated the 
onset-season as a candidate of prognostic factors, and onset in warm season was one of 
the factors which significantly protracted clinical course by univariate analysis. 
However, viral infection is usually more common in winter than summer [3] and onset 
in warm season did not remain significant by multivariate analysis. On the other hand, 
absence of atypical lymphocytes in peripheral blood and small number of blastic cells in 
the lymph node specimens (≤70%) were statistically significant factors which may 
protract the duration of this disease. Although also the steroid therapy showed a 
tendency to protract the duration of KFD, it might affect the selection bias because we 
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tend to undergo steroid therapy for the patients with serious conditions. Most 
proliferating cells in KFD are CD8-positive T cells and most apoptotic cells are also 
CD8-positive cytotoxic T cells [4]. In other words, CD8-positive cytotoxic T cells 
transforming to blastic cells undergo both apoptosis and proliferation simultaneously in 
KFD [5]. The apoptosis of CD8-positive cells (=blastic cells) are induced by Fas and 
perforin pathways, and the activated CD8-positive T-cell proliferating/dying functional 
balance might be beneficial to eradicate the responsible agent [6]. Leukopenia with low 
CD4+/CD8+ cell ratio usually appears in the early stages of KFD. It may be mainly due 
to the apoptosis of CD4-positive smaller cells which may also be induced by blastic 
transformed CD8-positive cells [7]. These activated CD8-positive T cells may transude 
to peripheral blood and be recognized as atypical lymphocytes. In the present study, 
elevation of serum level of sIL-2R was a positive prognostic factor which may shorten 
the duration of KFD, and it might also reflect the activation of CD8-poisitive T cells [8], 
although the data of sIL-2R was not perfect. Thus the patients with atypical 
lymphocytes in the peripheral blood, large number of blastic cells in the lymph nodes, 
and perhaps elevation of serum level of sIL-2R, may recover from KFD earlier. Of 
course open surgical biopsy is desirable to confirm the amount of blastic cells in the 
lymph nodes, but cutting needle biopsy can be alternative method if the manipulation is 
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well done [9, 10]. Detection of atypical lymphocytes in the peripheral blood may be the 
most convenient method to predict the duration of KFD. The cell composition varies 
from case to case and with time: there is a tendency that necrosis and degenerated 
predominant type is observed a little later than immunoblastic predominant type [7]. 
However, many cases are mixed type and the amount of coagulative necrosis was not 
associated with the disease duration in the present study.  
Some KFD cases are histological mimickers of SLE. Both clinically and 
histologically KFD and SLE exhibit a remarkable resemblance although no clearly 
identified relation has been found between KFD and SLE [1, 11]. Even by pathological 
examination only the presence of hematoxylin bodies and paucity of neutrophils provide 
a strong support for discrimination of KFD from SLE [12]. Among the 43 KFD patients 
in the present study, 1 patient who had generalized lymphadenopathy was diagnosed 
with concurrent SLE. In a large study, the frequency of suspected SLE among KFD 
patients was 5 of 108 [13], and in another analysis, 32 of 244 KFD patients had SLE [8]. 
Generalized lymphadenopathy has been reported in 1% to 22% of KFD cases and is 
much less frequent now than in the past [14]. KFD should be followed up long-term 
considering the possible development of SLE [11].  
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Conclusion 
In KFD, the patients with atypical lymphocytes in the peripheral blood and large 
number of blastic cells in the lymph nodes may recover from KFD earlier. Detection of 
atypical lymphocytes in the peripheral blood is the most convenient method to predict 
the duration of KFD. 
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Figure Legends 
 
Table 1. Univariate analysis of outcome for the duration of the 43 KFD patients 
Characteristics 
Number of 
patients (%) 
Treatment 
period 
(months) 
p-value 
Age          >30 years 18 (42) 10.9 
 
             ≤30  25 (58) 8.4 0.42 
Sex          male 14 (33) 8.4 
 
            female 29 (67) 9.9 0.58 
Fever         (+) 27 (63) 11.2 
 
              (-) 16 (37) 6.5 0.080  
Pain          (+) 24 (56) 10.3 
 
              (-) 19 (44) 8.3 0.48 
General fatigue  (+) 12 (28) 14.3 
 
               (-) 31 (72) 7.5 0.10  
Onset    (spring, summer) 25 (58) 11.7 
 
         (autumn, winter) 18 (42) 6.3 0.046 
WBC     >4000 (/μl)  23 (53) 10.3 
 
          ≤4000 20 (47) 8.4 0.49 
Atypical lymphocyte (+) 9 (21) 5.4 
 
                  (-) 34 (79) 10.5 0.043 
LDH         >230 (IU/L)  18 (42) 9.3 
 
             ≤230 25 (58) 9.5 0.95 
sIL-2R       >1000 (U/ml)   4* 4.3 
 
             ≤1000 18* 10.4 0.0050* 
CRP          >1 (mg/dl) 10 (23) 9.0  
 
             ≤1 33 (77) 9.5 0.85 
Smoker       Yes 14* 8.6 
 
              No 28* 9.1 0.58* 
Drinker       Yes 9* 14.1 
 
              No 33* 7.6 0.090* 
NSAID        (+) 38* 9.8 
 
              (-) 4* 5.3 0.15* 
Antibiotic      (+) 31 (72) 9.3 
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              (-) 12 (28) 9.9 0.86 
Steroid        (+) 12 (28) 14.1 
 
              (-) 31 (72) 7.6 0.087 
Area of blast cell proliferation in the 
lymph nodes    >70% 
10 (23) 5.6 
 
              ≤70% 33 (77) 10.6 0.040  
Area of Coagulative necrosis in the 
lymph nodes    >50% 
7 (16) 14.0  
 
              ≤50% 36 (84) 8.5 0.31 
KFD, Kikuchi-Fujimoto disease; WBC, white blood cell; LDH, lactate dehydrogenase; 
sIL-2r, soluble interleukin-2 receptor; CRP, c-reactive protein; NSAID, nonsteroidal 
anti-inflammatory drug. 
*The data were not perfect with some defect. 
 
 
 
Table 2. Multivariate analysis of outcome for the duration of the 43 KFD patients 
Prognostic factors 
Standard 
regression 
coefficient 
Standard 
error 
95% confidence 
interval 
P value 
Fever (+) 0.099 3.40  -4.28-8.09 0.54 
General fatigue (+) 0.18 3.96 -3.16-10.62 0.28 
Onset (spring, summer) 0.22 2.48 -0.91-9.16 0.11  
Atypical lymphocytes in 
peripheral blood (-) 
0.32 3.14 0.91-13.65 0.026 
Steroid (+) 0.29 3.56 -1.27-13.16 0.10  
Area of Blastic cell 
proliferation in the lymph 
nodes  ≤ 70% 
0.39 3.19 2.13-15.09 0.011 
KFD, Kikuchi-Fujimoto disease. 
 
 
 
 
 
 
17 
 
17 
 
Figure 1. 
 
(a) Large number of histiocytes existed at the margin of the necrotic area, and many of 
them were crescentic (Hematoxylin and Eosin stain ×40). Immunohistochemical studies 
showed (b) there was a predominance of CD8-positive large lymphoid cells with blastic 
features, (c) myeloperoxidase was detected among (d) lysozyme-positive histiocytes. 
(×40) 
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Figure 2.  
 
Representative pictures of high power view of Kikuchi-Fujimoto disease (Hematoxylin 
and Eosin stain ×40). (a) The case with occupation of blastic cells in the lymph node 
more than 70%. (b) The case with occupation of coagulative necrosis in the lymph node 
more than 50%. 
